Utility assessments of opioid treatment for chronic pain

Pain Medicine

Volumn 3, Issue 3, 2002, Pages 218-230

  Schmier, Jordana K ^a   Palmer, Cynthia S ^b   Flood, Emuella M ^c   Gourlay, Geoffrey ^d  

^a EXPONENT INC   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Chronic cancer pain; Chronic noncancer pain; Opioids; Patient preference; Quality of life; Utilities

Indexed keywords

ANALGESIC AGENT; FENTANYL; MORPHINE; OPIATE;

ADULT; ANALGESIA; ARTICLE; AWARENESS; CANCER; CHRONIC PAIN; COMPUTER SYSTEM; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATION DEPRESSION; SLEEP DISORDER; SOMNOLENCE; SWEATING; TREATMENT OUTCOME;

EID: 0036421911     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2002.02045.x     Document Type: Article

References (45)

1. Krames ES, Olson K. Clinical realities and economic considerations: Patient selection in intrathecal therapy. J Pain Symptom Manage 1997;14(3 Suppl):S3-13.
2. Garcia J, Altman RD. Chronic pain states: pathophysiology and medical therapy. Semin Arthritis Rheum 1997;27:1-16.
3. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: A multicenter study in patients with cancer pain. Pain 1996;64:527-34.
4. Leelanuntakit S. Management of cancer-related pain with transdermal fentanyl. J Med Assoc Thai 1996;79:341-6.
5. World Health Organization. Cancer pain relief and palliative care, second edition. Geneva: World Health Organization; 1990.
6. Ahmedzai S. New approaches to pain control in patients with cancer. Eur J Cancer 1997; 33 (Suppl 6):S8-14.
7. Payne R, Chandler S, Einhaus M. Guidelines for the clinical use of transdermal fentanyl. Anticancer Drugs 1995;6(Suppl 3):50-3.
8. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000;320:1530-3.
9. Cleary PD. The increasing importance of patient surveys: Now that sound methods exist, patient surveys can facilitate improvement. BMJ 1999;319:720-1.
10. Ryan M. Measuring benefits in health care: The role of discrete choice conjoint analysis. Presented at the International Health Economics Association Meeting: Rotterdam, The Netherlands; 1999a.
11. Lancaster K. A new approach to consumer theory. J Political Econ 1966;74:134-57.
12. Lancaster K. Consumer demand. New York: Columbia University Press, 1971.
13. Hanemann W. Welfare evaluations in contingent valuation experiments with discrete responses: Reply. Am J Agricultur Econ 1984;69:332-41.
14. Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF. The measurement of patients' values in medicine. Med Decis Making 1982;2:449-62.
15. Bryan S, Buxton M, Sheldon R, Grant A. Magnetic resonance imaging for the investigation of knee injuries: An investigation of preference. Health Econ 1998;7:595-603.
16. Propper C. Contingent valuation of time spent on NHS waiting list. Econ J 1991;100:193-9.
17. Propper C. The disutility of time spent on the United Kingdom's National Health Service waiting lists. J Hum Resources 1995;30:677-700.
18. Ratcliffe J, Buxton M. Patient's preferences regarding the process and outcomes of life-saving technology: An application of conjoint analysis to liver transplantation. Int J Technol Assess Health Care 1999;15:340-51.
19. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: An application to in vitro fertilisation. Soc Sci Med 1999;8:535-46.
20. van der Pol M, Cairns J. Establishing patient preferences for blood transfusion support: An application of conjoint analysis. J Health Serv Res Policy 1998;3:70-6.
21. Ryan M, McIntosh E, Shackley P. Using conjoint analysis to elicit the views of health service users: An application to the patient health card. Health Expect 1998;1:117-29.
22. Farrar S, Ryan M, Ross D, Ludbrook A. Using discrete choice modelling in priority setting: An application to clinical service developments. Soc Sci Med 2000;50:63-75.
23. Hakim Z, Pathak DS. Modelling the EuroQol data: A comparison of discrete choice conjoint and conditional preference modelling. Health Econ 1999;8:103-16.
24. Maas A, Stalpers L. Assessing utilities by means of conjoint measurement: An application in medical decision analysis. Med Decis Making 1992;12:288-97.
25. Verhoef C, Maas A, Stalpers L, Verbeek A, Wobbes T, Daal W. The feasibility of additive conjoint measurement in measuring utilities in breast cancer patients. Health Policy 1991;17:39-50.
26. Ryan M, Hughes J. Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 1997;6:261-73.
27. Vick S, Scott A. Agency in health care: Examining patients' preferences for attributes of the doctor-patient relationship. J Health Econ 1998;17:587-606.
28. Scott A, Vick S. Patients, doctors and contracts: An application of principal-agent theory to the doctor-patient relationship. Scot J Political Econ 1999;46: 111-34.
29. Harwood RH, Rogers A, Dickinson E, Ebrahim S. Measuring handicap: The London Handicap Scale, a new outcome measure for chronic disease. Qual Health Care 1994;3:11-6.
30. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
31. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cun A, Duez NJ, et al. The European Organization for Research and treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
32. Sawtooth Software. ACA system version 4.0. Sequim, WA: Sawtooth Software.
33. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: A user manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
34. Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30-reference values from a large sample of Swedish population. Acta Oncol 2000;39:477-84.
35. Klepstad P, Borchgrevink PC, Kaasa S. Effects on cancer patient's health-related quality of life after the start of morphine therapy. J Pain Symptom Manage 2000;20:19-26.
36. Bonomi AE, Shikiar R, Legro MW. Quality-of-life assessment in acute, chronic, and cancer pain: A pharmacist's guide. J Am Pharm Assoc (Wash) 2000; 40:402-16.
37. Ahmedzai S. Recent clinical trials of pain control: Impact on quality of life. Eur J Cancer 1995,31A (Suppl 6):S2-7.
38. Becker N, Bondegaard TA, Olsen AK, Sjogren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997;73:393-400.
39. Glick HA, Polsky D, Willke RJ, Schulman K. A comparison of preference assessment instruments used in a clinical trial: Responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making 1999;19:265-75.
40. Kaplan RM, Anderson JP, Wu AW, Mathews WC, Kozin F, Orenstein D. The Quality of Well-Being Scale: Applications in AIDS, cystic fibrosis, and arthritis. Med Care 1989;27(3 Suppl):S27-43.
41. Erickson P. Modeling health-related quality of life: The bridge between psychometric and utility-based measures. J Natl Cancer Inst Monogr 1996; (20):17-22.
42. Rabin R, Rosser RM, Butler C. Impact of diagnosis on utilities assigned to states of illness. J R Soc Med 1993;86:444-8.
43. Keefe FJ, Lefebvre JC, Egert JR, Affleck G, Sullivan MJ, Caldwell DS. The relationship of gender to pain, pain behavior, and disability in osteoarthritis patients: the role of catastrophizing. Pain 2000;87:325-34.
44. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the short form 36-item health survey (SF-36). BrJ Rheumatol 1998;37:425-36.
45. Nichol MB, Harada AS. Measuring the effects of medication use on health-related quality of life in patients with rheumatoid arthritis. A review. Pharmacoeconomics 1999;16:433-48.